A statistical analysis plan for the Adjunctive Corticosteroids for Tuberculous meningitis in HIV-positive adults (ACT HIV) clinical trial [version 2; peer review: 3 approved]
TBM is the most severe form of tuberculosis. Clinical trial data are required to provide an evidence base for adjunctive dexamethasone in HIV-positive individuals with TBM, and to guide clinical practice. This document details the planned analyses at 12 months post randomisation for the ACT HIV clin...
Main Authors: | Ronald B. Geskus, Joseph Donovan, Guy E. Thwaites, Trinh Dong Huu Khanh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wellcome
2022-07-01
|
Series: | Wellcome Open Research |
Subjects: | |
Online Access: | https://wellcomeopenresearch.org/articles/6-280/v2 |
Similar Items
-
Presentation of Tuberculous Meningitis
by: Salma Haji
Published: (2020-09-01) -
A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults
by: Nguyen TH Mai, et al.
Published: (2018-02-01) -
Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis
by: Caleb P. Skipper, et al.
Published: (2022-09-01) -
Urine retention as presenting manifestation of tuberculous meningitis complicated by lacunar infarction and transverse myelitis: Case report and literature review
by: Ahmed Salih Abdulhadi, et al.
Published: (2021-07-01) -
Outcome of Tuberculous Meningitis in Adults
by: Salma Haji
Published: (2019-03-01)